newsfilter
← Latest News
GlobeNewswire·

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced an agreement for $100 million in funding to Zealand Pharma in exchange for Zealand Pharma’s economics related to rusfertide